Filed under: Analyst upgrades and downgrades

MOST NOTEWORTHY: Acadia Pharmaceuticals, Genesis Microchip and SAFECO Corp were today’s noteworthy upgrades:

  • JMP Securities upgraded Acadia Pharmaceuticals (NASDAQ: ACAD) to Strong Buy from Market Outperform, citing increased confidence in the company’s pimavanserin for combination treatment of schizophrenia.
  • Genesis Microchip (NASDAQ: GNSS) was upgraded to Hold from Underperform at Jefferies to reflect the acquisition by STMicroelectronics (NYSE: STM). The firm does not expect additional competitive offers.
  • SAFECO (NYSE: SAF) was upgraded to Market Perform from Underperform at Friedman Billings based on improved outlook and valuation.

OTHER UPGRADES:

Permalink | Email this | Comments

You might also be interested in these

Leave a Reply

Close
E-mail It